1. Home
  2. List
Reference Patent

Reference - List

  • 19 Hits
  • Search Condition : Filter (MeSH = Nanoparticles / administration & dosage*)
Species Resource Title
Human and Animal Cells PK-1(RCB1972) Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14-specific chimeric siRNA/nanocarrier complex.
Human and Animal Cells MBT-2(RCB0544) Nanoparticulation of BCG-CWS for application to bladder cancer therapy.
Human and Animal Cells Colon-26(RCB2657) A novel nitric oxide-based anticancer therapeutics by macrophage-targeted poly(l-arginine)-based nanoparticles.
Human and Animal Cells KGN(RCB1154) Carbon Black Nanoparticles Inhibit Aromatase Expression and Estradiol Secretion in Human Granulosa Cells Through the ERK1/2 Pathway.
Human and Animal Cells MH7A(RCB1512) Oxygen and indocyanine green loaded phase-transition nanoparticle-mediated photo-sonodynamic cytotoxic effects on rheumatoid arthritis fibroblast-like synoviocytes.
Human and Animal Cells MKN45(RCB1001) Theranostic Photosensitive Nanoparticles for Lymph Node Metastasis of Gastric Cancer.
Human and Animal Cells A549(RCB0098) Nitrative DNA damage in lung epithelial cells exposed to indium nanoparticles and indium ions.
Human and Animal Cells MCF7(RCB1904) Photodynamic therapy at ultra-low NIR laser power and X-Ray imaging using Cu3BiS3 nanocrystals.
Human and Animal Cells HeLa(RCB0007) Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery.
Human and Animal Cells HeLa Synergism between a cell penetrating peptide and a pH-sensitive cationic lipid in efficient gene delivery based on double-coated nanoparticles.
Human and Animal Cells Colon-26(RCB2657) Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects.
Human and Animal Cells LLC(RCB0558) Comprehensive Mechanism Analysis of Mesoporous-Silica-Nanoparticle-Induced Cancer Immunotherapy.
Human and Animal Cells OVK18(RCB1903) Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Human and Animal Cells CACO-2(RCB0988) Cytotoxic effects of fucoidan nanoparticles against osteosarcoma.
Human and Animal Cells Colon-26(RCB2657) Combination Treatment of Murine Colon Cancer with Doxorubicin and Redox Nanoparticles.
Human and Animal Cells SK-BR-3(RCB2132) Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells.
Human and Animal Cells HCE-T(RCB2280) Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model.
Human and Animal Cells LM8(RCB1450) Development of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles.
Mice RBRC01059 Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model.